title: Implications of intrapartum azithromycin on neonatal microbiota.
authors.affiliation: David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
authors.forename: Jenny
authors.initials: J
authors.lastname: Mei
authors.affiliation: Zuckerberg San Francisco General Hospital, San Francisco, CA 94110, USA; School of Pharmacy, UCSF, San Francisco, CA, USA.
authors.forename: Kristin
authors.initials: K
authors.lastname: Harter
authors.affiliation: Zuckerberg San Francisco General Hospital, San Francisco, CA 94110, USA; Department of Pediatrics, UCSF, San Francisco, CA, USA.
authors.forename: Olivier
authors.initials: O
authors.lastname: Danhaive
authors.affiliation: Zuckerberg San Francisco General Hospital, San Francisco, CA 94110, USA; Department of Obstetrics, Gynecology, and Reproductive Sciences, UCSF, San Francisco, CA, USA.
authors.forename: Dominika
authors.initials: D
authors.lastname: Seidman
authors.affiliation: Zuckerberg San Francisco General Hospital, San Francisco, CA 94110, USA; Department of Obstetrics, Gynecology, and Reproductive Sciences, UCSF, San Francisco, CA, USA. Electronic address: juan.vargas@ucsf.edu.
authors.forename: Juan
authors.initials: J
authors.lastname: Vargas
mesh_terms: D000900:Anti-Bacterial Agents; D017963:Azithromycin; D064307:Microbiota
chemical_list: D000900:Anti-Bacterial Agents; D017963:Azithromycin